Endo International | ENDP - SCHULD



SCHULD Veränderung Datum
AbbVie USD 72.86B 5.36B 2026-03
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 43.37B 867M 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Ligand Pharmaceuticals USD 451.98M 486K 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pfizer USD 63.19B 536M 2026-06
Phibro Animal Health USD 474.17M 730K 2024-09
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Takeda JPY 4.94T 58.13B 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Xeris Pharmaceuticals USD 258.55M 899K 2026-03
Zoetis USD 9.24B 0 2026-03